Skip to content

13F-HR filed by ACORN CAPITAL ADVISORS, LLC

ACORN CAPITAL ADVISORS, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 15:22:05 UTC, with 22 holding rows worth $363,951,897.

Accession
0001636587-26-000102
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 22 entries on the cover page, a total value of $363,951,897 stated on the cover page (in dollars after the unit check, H1), rows summing to $363,951,897 with VALUE read as dollars as filed, 13F file number 028-25253. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CG ONCOLOGY INC156944100COMMON STOCK1,131,500$80,212,075dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK1,648,420$66,975,305dollars as filed
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK4,131,299$41,023,799dollars as filed
CANDEL THERAPEUTICS INC137404109COMMON STOCK3,497,948$36,518,577dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock2,144,844$30,714,166dollars as filed
CYBIN INC23256X407COM NEW1,540,266$18,929,870dollars as filed
JADE BIOSCIENCES INC008064206COM NEW986,760$13,863,978dollars as filed
BICARA THERAPEUTICS INC055477103COM668,381$12,438,582dollars as filed
VERASTEM INC92337C203COMMON STOCK1,469,153$11,826,682dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A2,839,674$7,752,310dollars as filed
ENGENE THERAPEUTICS INC29286X101COM3,811,782$7,623,564dollars as filed
AN2 THERAPEUTICS INC037326105COM1,300,000$6,916,000dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK1,025,349$6,439,192dollars as filed
PROTARA THERAPEUTICS INC74365U107COM STK1,752,115$5,343,951dollars as filed
ANNEXON INC03589W102COM1,136,974$4,809,400dollars as filed
LeonaBio Inc04746L203COM1,144,416$4,085,565dollars as filed
WHITEHAWK THERAPEUTICS INC00032Q104CMN932,139$3,504,843dollars as filed
Q32 BIO INC746964105Common Stock216,171$1,787,734dollars as filed
KARYOPHARM THERAPEUTICS INC48576U205COMMON STOCK1,222,019$1,490,863dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW1,438,159$834,132dollars as filed
VYNE THERAPEUTICS INC92941V308COM32,005$720,744dollars as filed
BIOATLA INC09077B104COM108,127$140,565dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001636587-26-000102this filing2026-11-16